作者回应:平衡的电解质溶液在糖尿病酸性脂肪酸症中:斯特洛芬丁在哪里?
Priyanka Gupta1, Prashant Nasa2
1Department of Pulmonary Medicine and Critical Care, Lifecare Hospital (Burjeel Group), Musaffah, Abu Dhabi, United Arab Emirates.
概括
糖尿病酸症 (DKA) 的管理需要谨慎的液体和电解质平衡. 斯特罗芬丁是一种平衡的电解质溶液,根据其成分和潜在的益处,被评估其在DKA治疗中的作用.
科学领域:
- 关键护理医学 关键护理医学
- 内分泌学 在内分泌学.
- 临床药房 临床药房
背景情况:
- 糖尿病酸性酸症 (DKA) 是糖尿病的危及生命的并发症.
- 液体和电解质管理在DKA治疗中至关重要.
- 平衡电解质溶液 (BES) 越来越多地使用,但它们在DKA中的作用需要进行具体的评估.
研究的目的:
- 评估Sterofundin,一种特定的平衡电解质溶液在糖尿病酸性脂肪酸症的管理中的适用性和位置.
- 在DKA治疗目标的背景下,审查Sterofundin的电解质成分.
主要方法:
- 文献审查和现有临床指南和研究的分析.
- 斯特罗芬丁的电解质谱与DKA管理的推参数的比较.
- 讨论在DKA中使用斯特罗芬丁的潜在优点和缺点.
主要成果:
- 斯特罗芬丁含有电解质,如,,和乳酸盐.
- 它的成分与DKA液体复苏的某些方面保持一致,特别是关于和水平.
- 潜在的担忧包括其乳酸含量和度在某些DKA场景.
结论:
- 斯特罗芬丁可以被认为是DKA的流体选择,但仔细监测患者是必不可少的.
- 它的使用应以个体患者的需要和电解质状况的持续评估为指导.
- 需要进一步的研究来确定斯特罗芬丁在DKA管理中的作用.
相关概念视频
Roles of Electrolytes: Chloride and Bicarbonate
120
Chloride ions contribute to the osmotic pressure gradient distinguishing the intracellular fluid (ICF) from the extracellular fluid (ECF). They counterbalance positively charged ions in the ECF and ensure its electrochemical stability. The renal system's process of chloride absorption and release generally mirrors that of sodium ions.
Conditions such as hypochloremia can arise from insufficient chloride reabsorption by the kidneys, often compounded by extended bouts of diarrhea, vomiting,...
Conditions such as hypochloremia can arise from insufficient chloride reabsorption by the kidneys, often compounded by extended bouts of diarrhea, vomiting,...
120
Heart Failure Drugs: Diuretics
312
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
312
Heart Failure Drugs: Inotropic Agents
479
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
479
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Homeostatic Imbalance
21.4K
Homeostasis is the maintenance of a stable internal environment within the body, which is crucial for the proper functioning of cells, tissues, organs, and organ systems. The body has various control mechanisms that work together to regulate various physiological parameters such as temperature, blood pressure, pH balance, and fluid balance, to name a few. These control mechanisms are based on feedback loops that can be either positive or negative.
However, sometimes these feedback loops fail,...
However, sometimes these feedback loops fail,...
21.4K
Hypoglycemia and Glucagon
146
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
146


